Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Developmental changes in serum concentrations of desipramine and 2-hydroxydesipramine during treatment with desipramine.

Wilens TE, Biederman J, Baldessarini RJ, Puopolo PR, Flood JG.

J Am Acad Child Adolesc Psychiatry. 1992 Jul;31(4):691-8.

PMID:
1644733
2.

Electrocardiographic effects of desipramine and 2-hydroxydesipramine in children, adolescents, and adults treated with desipramine.

Wilens TE, Biederman J, Baldessarini RJ, Puopolo PR, Flood JG.

J Am Acad Child Adolesc Psychiatry. 1993 Jul;32(4):798-804.

PMID:
8340301
3.

Hydroxydesipramine in the elderly.

Nelson JC, Atillasoy E, Mazure C, Jatlow PI.

J Clin Psychopharmacol. 1988 Dec;8(6):428-33.

PMID:
3235701
4.

Evidence for altered desipramine disposition in methadone-maintained patients treated for cocaine abuse.

Kosten TR, Gawin FH, Morgan C, Nelson JC, Jatlow P.

Am J Drug Alcohol Abuse. 1990;16(3-4):329-36.

PMID:
2288330
5.

The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma.

Cooke RG, Warsh JJ, Stancer HC, Reed KL, Persad E.

Clin Pharmacol Ther. 1984 Sep;36(3):343-9.

PMID:
6467794
6.

2-Hydroxydesipramine and desipramine plasma levels and electrocardiographic effects in depressed younger adults.

Stern SL, Ribner HS, Cooper TB, Nelson LD, Johnson MH, Suckow RF.

J Clin Psychopharmacol. 1991 Apr;11(2):93-8.

PMID:
2056147
7.

Desipramine and 2-hydroxydesipramine plasma levels in endogenous depressed patients. Lack of correlation with therapeutic response.

Amsterdam JD, Brunswick DJ, Potter L, Winokur A, Rickels K.

Arch Gen Psychiatry. 1985 Apr;42(4):361-4.

PMID:
3977553
8.

Antidepressant activity of 2-hydroxydesipramine.

Nelson JC, Mazure C, Jatlow PI.

Clin Pharmacol Ther. 1988 Sep;44(3):283-8.

PMID:
3416551
9.

2-Hydroxydesipramine and desipramine plasma levels: how are they related to antidepressant response?

Stern SL, Cooper TB, Nelson LD, Johnson MH, Suckow RF.

Int Clin Psychopharmacol. 1996 Dec;11(4):219-27.

PMID:
9031987
10.

Possible nonlinear pharmacokinetics of desipramine after once daily dosing.

Amsterdam JD, Brunswick DJ, Potter L, Rickels K.

Pharmacopsychiatry. 1986 Mar;19(2):84-7.

PMID:
3703927
11.

Clinical implications of 2-hydroxydesipramine plasma concentrations.

Nelson JC, Bock JL, Jatlow PI.

Clin Pharmacol Ther. 1983 Feb;33(2):183-9.

PMID:
6822031
12.

Plasma desipramine levels and ECG changes in depressed young adults.

Barnhill JG.

J Clin Psychopharmacol. 1992 Apr;12(2):136-7. No abstract available.

PMID:
1573037
13.

Desipramine clearance in children and adolescents: absence of effect of development and gender.

Cohen LG, Biederman J, Wilens TE, Spencer TJ, Mick E, Faraone SV, Prince J, Flood JG.

J Am Acad Child Adolesc Psychiatry. 1999 Jan;38(1):79-85.

PMID:
9893420
14.

Desipramine dose prediction based on 24-hour single-dose levels: feasibility and validity.

Bertschy G, Vandel S, Vandel B, Allers G, Bechtel P, Volmat R.

Pharmacopsychiatry. 1989 Jul;22(4):161-4.

PMID:
2762378
15.

Plasma levels of imipramine and metabolites in 68 hospitalized children.

Preskorn SH, Bupp SJ, Weller EB, Weller RA.

J Am Acad Child Adolesc Psychiatry. 1989 May;28(3):373-5.

PMID:
2738003
16.

Response to desipramine treatment in adolescent depression: a fixed-dose, placebo-controlled trial.

Kutcher S, Boulos C, Ward B, Marton P, Simeon J, Ferguson HB, Szalai J, Katic M, Roberts N, Dubois C, et al.

J Am Acad Child Adolesc Psychiatry. 1994 Jun;33(5):686-94.

PMID:
8056732
17.
18.

[Clinical usefulness of monitoring serum levels of imipramine and desipramine in patients treated for endogenous depression].

Szymura-Oleksiak J, Wasieczko A.

Psychiatr Pol. 1991 Jan-Feb;25(1):54-60. Polish.

PMID:
1780375
19.

Active metabolites of imipramine and desipramine in man.

Potter WZ, Calil HM, Sutfin TA, Zavadil AP 3rd, Jusko WJ, Rapoport J, Goodwin FK.

Clin Pharmacol Ther. 1982 Mar;31(3):393-401.

PMID:
7060321
20.

Altered hydroxydesipramine concentrations in elderly depressed patients.

Kitanaka I, Ross RJ, Cutler NR, Zavadil AP 3rd, Potter WZ.

Clin Pharmacol Ther. 1982 Jan;31(1):51-5.

PMID:
7053304

Supplemental Content

Support Center